Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
'Dancing With the Stars' Veteran Stephani Sosa Tackles Ozempic Buzz - Featured image
Celebrity News

'Dancing With the Stars' Veteran Stephani Sosa Tackles Ozempic Buzz

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 12, 2026·2 min read

On this page

  • Stephani Sosa's Ozempic Journey
  • Understanding Semaglutides
  • Body Transformation Efforts
  • Future Endeavors

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Former 'Dancing With the Stars' troupe member Stephani Sosa openly discusses her use of Ozempic during the show and her ongoing health journey. She also shares details about liposuction and maintaining a fit lifestyle post-procedure. As she moves away from the series, Sosa focuses on new acting opportunities and personal growth.

Share

On this page

  • Stephani Sosa's Ozempic Journey
  • Understanding Semaglutides
  • Body Transformation Efforts
  • Future Endeavors

Stephani Sosa's Ozempic Journey

Former troupe dancer on 'Dancing With the Stars,' Stephani Sosa, has revealed her past with the debated weight-loss drug Ozempic.

'Folks have inquired whether I'm taking Ozempic, and yes, I used it during last season's 'Dancing With the Stars,' Sosa, aged 26, stated in a TikTok clip posted on Saturday, January 10. 'I aimed to appear my finest possible. This marked my debut living my aspiration on screen, and I sought perfection.'

Stephani, sibling to DWTS professional Ezra Sosa, acted as a troupe performer in season 33 during autumn 2024.

'I took Ozempic previously, but I've stopped now,' Stephani clarified on Saturday. 'My physique responded positively. I'd been using it for an extended period before joining 'Dancing With the Stars.''

Understanding Semaglutides

Medications such as Ozempic, Wegovy, and Mounjaro frequently aid in long-term weight control for adults dealing with obesity or excess weight linked to issues like elevated blood pressure or type 2 diabetes. However, medical experts often advise against employing GLP-1 agonists for routine slimming, particularly among public figures.

Body Transformation Efforts

Regarding Stephani, she has previously spoken openly on her self-perception and opted for 360 liposuction to 'totally reshape my figure.'

'I aimed to contour my physique and battled lifelong challenges to attain the body I've desired,' Stephani expressed in a December 2024 TikTok post. 'I pursued this for myself and my profession. I grew weary of the entertainment world dictating body standards, so I took action personally.'

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Following the surgery, Stephani maintains a consistent exercise regimen and consumes mostly wholesome meals.

'My appearance shifted dramatically, combining the procedure with guidance from a personal coach and nutritious eating,' she summed up. 'It proved the wisest choice; my existence transformed, boosting self-assurance and joy.'

Future Endeavors

Stephani performed solely in DWTS season 33.

'I won't reprise my troupe role this season; it's tough, as this program has been a lifelong dream,' she posted on Instagram in September 2025, ahead of season 34's launch. 'I'm thrilled for the incoming troupe—you'll excel. Regarding my participation, I was invited for ensemble routines, though specifics remain unclear.'

She added, 'Moving forward, I'll advance my acting path, concentrating on television, cinema, and performances. Exciting ventures await! This opportunity reshaped my world. Gratitude for your affection and backing, particularly as a Latina pioneering new territories—it deeply matters.'

Health tracking apps like Shotlee can assist in monitoring progress after such transformations and lifestyle shifts.

Source Information

Originally published by Us Weekly.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less
Medical Insights

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

New data presented at ENDO 2026 reveals a paradox: patients on GLP-1 medications like Ozempic and Wegovy reduced their physical activity despite losing weight.

8 min read
Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging
Medical Research

Popular Weight-Loss Drugs Ozempic and Wegovy May Slow Biological Aging

A new clinical trial suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may help slow biological processes associated with aging in adults with HIV.

8 min read
Yes, GLP-1s Make You Thinner. But Do They Make You Freer?
Health & Wellness

Yes, GLP-1s Make You Thinner. But Do They Make You Freer?

While GLP-1 drugs like Ozempic and Wegovy offer significant medical benefits, their rise raises critical questions about freedom, body image, and the cultural pressure to be thinner.

8 min read

Same topic: Weight Loss Medications

All Weight Loss Medications articles →
The Next Ozempic: A 4-in-1 Breakthrough for Lasting Weight Loss
Medical Research

The Next Ozempic: A 4-in-1 Breakthrough for Lasting Weight Loss

While Ozempic and similar GLP-1 agonists have revolutionized weight management, new research from Tufts University is exploring a novel 4-in-1 peptide that targets four hormone receptors for potentially greater efficacy and fewer side effects, moving closer to the gold standard of bariatric surgery.

6 min read
GLP-1 Medications for Obesity: Experts See a Broader Revolution Ahead
Health & Wellness

GLP-1 Medications for Obesity: Experts See a Broader Revolution Ahead

While GLP-1 receptor agonists have significantly advanced obesity treatment, specialists highlight the evolving landscape of comprehensive, personalized care that integrates various therapeutic strategies.

6 min read
Ozempic's Oral Twin: A Needle-Free Weight Loss Revolution Arrives?
Weight Management

Ozempic's Oral Twin: A Needle-Free Weight Loss Revolution Arrives?

A new era in weight management may be dawning as an oral medication, mirroring the efficacy of popular injectables like Ozempic, is poised for approval. This development promises a more accessible and convenient path to weight loss for millions.

7 min read

More in Celebrity News

TikTok influencer Anna Paul counters critic on 'Ozempic bruises'
Celebrity News

TikTok influencer Anna Paul counters critic on 'Ozempic bruises'

Social media personality Anna Paul has responded to a detractor who pointed out what they believed was an 'Ozempic bruise' in a shared image. She clarified that the discoloration resulted from a cycling mishap, not the weight-loss medication. This incident follows earlier worries about her health after a relationship breakup.

2 min read
Ozempic, Wegovy, Mounjaro: How Long Do GLP-1s Stay in Your System?
Weight Management

Ozempic, Wegovy, Mounjaro: How Long Do GLP-1s Stay in Your System?

Curious about how long Ozempic, Wegovy, Mounjaro, or other GLP-1 medications stay in your system after your last dose? This comprehensive guide explores the science behind their elimination and what factors influence their duration.

7 min read
DIY Weight Loss Injections: The Dangerous Rise of 'Skinny Jabs'
Weight Management

DIY Weight Loss Injections: The Dangerous Rise of 'Skinny Jabs'

As the cost of popular weight loss medications like Mounjaro and Wegovy climbs, a growing number of individuals are resorting to dangerous, unapproved DIY 'skinny jabs' sourced illegally online. This article delves into the risks, motivations, and the alarming reality of this trend.

7 min read
Share this article
  1. Home
  2. Blog
  3. 'Dancing With the Stars' Veteran Stephani Sosa Tackles Ozempic Buzz
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community